Pre Tax Profit 更改
Gilead Sciences USD 2.59B 586M 2023-12
RedHill Biopharma USD -3729000 7.98M 2022-12
Supernus Pharmaceuticals USD 990K 38.1M 2023-12



Intra Cellular Therapies 税前利润 - 当前值,历史数据,预测,统计,图表和经济日历 - May 2024.